Efficacy and safety of antifibrotic drugs for interstitial lung diseases other than IPF: A systematic review, meta-analysis and trial sequential analysis.
<h4>Background</h4>The therapeutic role of antifibrotic therapy has been well-established in idiopathic pulmonary fibrosis (IPF). However, its efficacy and safety for interstitial lung diseases (ILDs) other than IPF are not fully understood.<h4>Methods</h4>We updated a system...
Saved in:
Main Authors: | Mei Yang, Yuying Tan, Ting Yang, Dan Xu, Mei Chen, Lei Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0318877 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype
by: Xinzhi Xu, et al.
Published: (2025-02-01) -
Effect of noninvasive respiratory support on interstitial lung disease with acute respiratory failure: A systematic review and meta-analysis
by: Natthawan Sanguanwong, et al.
Published: (2023-11-01) -
Long-term efficacy and safety of endoscopic surgery versus small bone window craniotomy for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis and trial sequential analysis
by: Chen Guo, et al.
Published: (2025-02-01) -
Real World Experience: Impact of a Specialist Interstitial Lung Disease Nurse on Health Care Utilization
by: Onofre Morán-Mendoza, et al.
Published: (2025-04-01) -
Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey
by: Emil Vilstrup Moen, et al.
Published: (2025-02-01)